Page 782 - Williams Hematology ( PDFDrive )

756 Part VI: The Erythrocyte Chapter 48: The Thalassemias: Disorders of Globin Synthesis 757

162. Ausió J, Levin DB, De Amorim GV, et al: Syndromes of disordered chromatin remodel- 198. Ho PJ, Hall GW, Luo LY, et al: Beta thalassaemia intermedia: Is it possible to predict
ing. Clin Genet 64:83, 2003. phenotype from genotype? Br J Haematol 100:70, 1998.
163. Gibbons RJ, McDowell TL, Raman S, et al: Mutations in ATRX, encoding a SWI/ 199. Rund D, Oron-Karni V, Filon D, et al: Genetic analysis of beta-thalassemia intermedia
SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet in Israel: Diversity of mechanisms and unpredictability of phenotype. Am J Hematol
24:368, 2000. 54:16, 1997.
164. Weatherall DJ, Old J, Longley J, et al: Acquired haemoglobin H disease in leukaemia: 200. Rund D, Fucharoen S: Genetic modifiers in hemoglobinopathies. Curr Mol Med 8:600,
Pathophysiology and molecular basis. Br J Haematol 38:305, 1978. 2008.
165. Gibbons RJ: alpha-Thalassemia, mental retardation, and myelodysplastic syndrome. 201. Wonke B, Hoffbrand AV, Bouloux P, et al: New approaches to the management of hep-
Cold Spring Harb Perspect Med 2:a011759, 2012. atitis and endocrine disorders in Cooley’s anemia. Ann N Y Acad Sci 850:232, 1998.
166. Belickova M, Schroeder HW, Guan YL, et al: Clonal hematopoiesis and acquired thalas- 202. Girot R, Lefrére JJ, Schettini F, et al: HIV infection and AIDS in thalassemia, in Thalas-
semia in common variable immunodeficiency. Mol Med 1:56, 1995. semia 1990: 5th Annual Meeting of the COOLEY-CARE Group, edited by Rebulla P, Fessas
167. Weatherall DJ, Clegg JB, Naughton MA: Globin synthesis in thalassemia: An in vitro P, p 69. Centro Trasfusionale Ospedale Maggiore Policlinico Dio Milano, Athens, 1991.
study. Nature 208:1061, 1965. 203. Choudhury NV, Dubey ML, Jolly JG, et al: Post-transfusion malaria in thalassaemia
168. Weatherall DJ, Clegg JB, Na-Nakorn S, Wasi P: The pattern of disordered haemoglobin patients. Blut 61:314, 1990.
synthesis in homozygous and heterozygous beta-thalassaemia. Br J Haematol 16:251, 204. Chatterjee R, Katz M, Cox TF, Porter JB: Prospective study of the hypothalamic-pitu-
1969. itary axis in thalassaemic patients who developed secondary amenorrhoea. Clin Endo-
169. Fessas P: Inclusions of hemoglobin in erythroblasts and erythrocytes of thalassemia. crinol (Oxf) 39:287, 1993.
Blood 21:21, 1963. 205. Premawardhena A, Arambepola M, Katugaha N, et al: Is the beta thalassaemia trait of
170. Wickramasinghe SN, Hughes M: Some features of bone marrow macrophages in clinical importance? Br J Haematol 141:407, 2008.
patients with beta-thalassaemia. Br J Haematol 38:23, 1978. 206. Liang ST, Wong VCW, So WWK, et al: Homozygous alpha-thalassaemia: Clinical
171. Yataganas X, Fessas P: The pattern of hemoglobin precipitation in thalassemia and its presentation, diagnosis and management: A review of 46 cases. Br J Obstet Gynaecol
significance. Ann N Y Acad Sci 165:270, 1969. 92:680, 1985.
172. Finch CA, Deubelbeiss K, Cook JD, et al: Ferrokinetics in man. Medicine (Baltimore) 207. Beaudry MA, Ferguson DJ, Pearse K, et al: Survival of a hydropic infant with homozy-
49:17, 1970. gous alpha-thalassemia-1. J Pediatr 108:713, 1986.
173. Chalavelakis G, Clegg JB, Weatherall DJ: Imbalanced globin chain synthesis in hete- 208. Bianchi DW, Beyer EC, Stark AR, et al: Normal long-term survival with alpha thalas-
rozygous beta-thalassemic bone marrow. Proc Natl Acad Sci U S A 72:3853, 1975. semia. J Pediatr 108:716, 1986.
174. Rund D, Rachmilewitz E: Advances in the pathophysiology and treatment of thalas- 209. Gouttas A, Fessas P, Tsevrenis H, Xefteri E: Description d’une nouvelle variete d’anemie
semia. Crit Rev Oncol Hematol 20:237, 1995. hemolytique congenitale. Sang 26:911, 1955.
175. Schrier SL: Pathobiology of thalassemic erythrocytes. Curr Opin Hematol 4:75, 1997. 210. Rigas DA, Koler RD, Osgood EE: Hemoglobin H: Clinical, laboratory, and genetic stud-
176. Fibach E, Rachmilewitz E: The role of oxidative stress in hemolytic anemia. Curr Mol ies of a family with a previously undescribed hemoglobin. J Lab Clin Med 48:51, 1956.
Med 8:609, 2008. 211. Wasi P: Hemoglobinopathies in southeast Asia, in Distribution and Evolution of the
177. Yuan J, Angelucci E, Lucarelli G, et al: Accelerated programmed cell death (apoptosis) Hemoglobin and Globin Loci, edited by Bowman JE, p 179. Elsevier, New York, 1983.
in erythroid precursors of patients with severe beta-thalassemia (Cooley’s anemia). 212. Kattamis C, Tzotzos S, Kanavakis E, et al: Correlation of clinical phenotype to genotype
Blood 82:374, 1993. in haemoglobin H disease. Lancet 1:442, 1988.
178. Ager JAM, Lehmann H: Observations in some “fast” haemoglobins: K, J, N, and “Bart’s.” 213. Galanello R, Pirastu M, Melis MA, et al: Phenotype-genotype correlation in haemoglo-
Br Med J 1:929, 1958. bin H disease in childhood. J Med Genet 20:425, 1983.
179. Rigas DA, Kohler RD, Osgood EE: New hemoglobin possessing a higher electropho- 214. Fucharoen S, Winichagoon P, Pootrakul P, et al: Differences between two types of Hb H
retic mobility than normal adult hemoglobin. Science 121:372, 1955. disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb constant
180. Gabuzda TG, Nathan DG, Gardner FH: The turnover of hemoglobins A, F, and A(2) in spring. Birth Defects Orig Artic Ser 23:309, 1988.
the peripheral blood of three patients with thalassemia. J Clin Invest 42:1678, 1963. 215. Styles L, Foote DH, Kleman KM, et al: Hemoglobin H-Constant Spring disease: An
181. Loukopoulos D, Fessas P: The distribution of hemoglobin types in thalassemic erythro- under recognized, severe form of alpha thalassemia. Int J Pediatr Hematol Oncol 4:69,
cyte. J Clin Invest 44:231, 1965. 1977.
182. Nathan DG, Gunn RB: Thalassemia: The consequences of unbalanced hemoglobin syn- 216. Lie-Injo LE, Ganesan J, Clegg JB, Weatherall DJ: Homozygous state for Hb Constant
thesis. Am J Med 41:815, 1966. Spring (slow-moving Hb X components). Blood 43:251, 1974.
183. Rees DC, Porter JB, Clegg JB, Weatherall DJ: Why are hemoglobin F levels increased in 217. Derry S, Wood WG, Pippard MJ, et al: Hematologic and biosynthetic studies in
HbE/beta thalassemia? Blood 94:3199, 1999. homozygous hemoglobin Constant Spring. J Clin Invest 73:1673, 1984.
184. Thein SL, Weatherall DJ: A non-deletion hereditary persistence of fetal hemoglobin 218. Higgs DR, Pressley L, Clegg JB, et al: Detection of alpha thalassaemia in Negro infants.
(HPFH) determinant not linked to the β-globin gene complex, in Hemoglobin Switch- Br J Haematol 46:39, 1980.
ing, Part B: Cellular and Molecular Mechanisms, edited by Stamatoyannopoulos G, 219. Higgs DR, Lamb J, Aldridge BE, et al: Inadequacy of Hb Bart’s as an indicator of
Nienhuis AW, p 97. Alan R. Liss, New York, 1989. alpha-thalassaemia. Br J Haematol 48:177, 1982.
185. O’Donnell A, Premawardhena A, Arambepola M, et al: Age-related changes in adapta- 220. Silvestroni E, Bianco I, Reitano G: Three cases of homozygous delta beta-thalassemia
tion to severe anemia in childhood in developing countries. Proc Natl Acad Sci U S A (or microcythemia) with high haemoglobin F in a Sicilian family. Acta Haematol
104:9440, 2007. 40:220, 1968.
186. Multicentre study on prevalence of endocrine complications in thalassemia major. 221. Ramot BN, Ben-Bassat I, Gafni D, Zaanoon R: A family with three delta beta-thalas-
Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin semia homozygotes. Blood 35:158, 1970.
Endocrinol (Oxf) 42:581, 1995. 222. Tsistrakis GA, Amarantos SP, Konkouris LL: Homozygous beta delta-thalassaemia.
187. Wood JC, Enriquez C, Ghugre N, et al: Physiology and pathophysiology of iron cardio- Acta Haematol 51:185, 1974.
myopathy in thalassemia. Ann N Y Acad Sci 1054:386, 2005. 223. Efremov GD: Hemoglobins Lepore and anti-Lepore. Hemoglobin 2:197, 1978.
188. Ganz T, Nemeth E: Iron metabolism: Interactions with normal and disordered erythro- 224. Charache S, Clegg JB, Weatherall DJ: The Negro variety of hereditary persistence of
poiesis. Cold Spring Harb Perspect Med 2:a011668, 2012. fetal haemoglobin is a mild form of thalassaemia. Br J Haematol 34:527, 1976.
189. Olivieri NF, Brittenham GM: Iron-chelating therapy and the treatment of thalassemia. 225. Huisman TH, Miller A, Schroeder WA: A G gamma type of hereditary persistence of
Blood 89:739, 1997. fetal hemoglobin with beta chain production in cis. Am J Hum Genet 27:765, 1975.
190. Singer ST, Ataga KI: Hypercoagulability in sickle cell disease and beta-thalassemia. 226. Higgs DR, Clegg JB, Wood WG, Weatherall DJ: G gamma beta + type of hereditary
Curr Mol Med 8:639, 2008. persistence of fetal haemoglobin in association with Hb C. J Med Genet 16:288, 1979.
191. Morris CR, Kuypers FA, Kato GJ, et al: Hemolysis-associated pulmonary hypertension 227. Fessas P, Stamatoyannopoulos G: Hereditary persistence of fetal hemoglobin in Greece:
in thalassemia. Ann N Y Acad Sci 1054:481, 2005. A study and a comparison. Blood 24:223, 1964.
192. Weatherall DJ: Phenotype-genotype relationships in monogenic disease: Lessons from 228. Sofroniadou K, Wood WG, Nute PE, Stamatoyannopoulos G: Globin chain synthesis
the thalassaemias. Nat Rev Genet 2:245, 2001. in Greek type (A gamma) of hereditary persistence of fetal haemoglobin. Br J Haematol
193. Weatherall DJ, Pressley L, Wood WG, et al: The molecular basis for mild forms of 29:137, 1975.
homozygous beta thalassaemia. Lancet 1:527, 1981. 229. Clegg JB, Metaxatou-Mavromati A, Kattamis C, et al: Occurrence of G gamma Hb F in
194. Wainscoat JS, Old JM, Weatherall DJ, Orkin SH: The molecular basis for the clinical Greek HPFH: Analysis of heterozygotes and compound heterozygotes with beta thalas-
diversity of beta thalassaemia in Cypriots. Lancet 1:1235, 1983. saemia. Br J Haematol 43:521, 1979.
195. Labie D, Pagnier J, Lapoumeroulie C, et al: Common haplotype dependency of high G 230. Camaschella C, Oggiano L, Sampietro M, et al: The homozygous state of G to A–117A
gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell gamma hereditary persistence of fetal hemoglobin. Blood 73:1999, 1989.
anemia patients. Proc Natl Acad Sci U S A 82:2111, 1985. 231. Weatherall DJ, Cartner R, Clegg JB, et al: A form of hereditary persistence of fetal hae-
196. Thein SL, Sampietro M, Old JM, et al: Association of thalassaemia intermedia with a moglobin characterized by uneven cellular distribution of haemoglobin F and the pro-
beta-globin gene haplotype. Br J Haematol 65:370, 1987. duction of haemoglobins A and A2 in homozygotes. Br J Haematol 29:205, 1975.
197. Thein SL, Hesketh C, Wallace RB, Weatherall DJ: The molecular basis of thalassaemia 232. Silvestroni E, Bianco I: La Malattia Microdrepanocitica. Il Pensiero Scientifico, Rome,
major and thalassaemia intermedia in Asian Indians: Application to prenatal diagnosis. 1955.
Br J Haematol 70:225, 1988. 233. Serjeant GR: Sickle Cell Disease, 3rd ed. Oxford University Press, New York, 2001.

Kaushansky_chapter 48_p0725-0758.indd 757 9/18/15 2:58 PM